The nootropic supplement market is expected to expand from US$ 2,200 million in 2023 to US$ 4,180 million by 2033. From 2023 to 2033, global nootropic supplement sales are likely to soar at 9.0% CAGR.
A nootropic supplement, or smart drug, is a compound that presents high attractiveness to consumers who prefer more lasting mental activity and focus. Nootropics are used to treat diseases such as Alzheimer's since they offer numerous benefits for brain health and cognitive aptitude.
Primarily, this supplement is sold to consumers through two formats. One is through over-the-counter, where an individual has access to a range of nootropic supplements that do not require any prescription from a doctor or a professional. Conversely, the prescribed format refers to the nootropic supplement that can be accessed only after getting approval from a doctor or health professional.
Hectic, urban lifestyles have increased cognitive, focus, and other related health concerns. To reduce these concerns, there is a growing preference for nootropic supplement added to meals and on-the-go products that are easy to consume and widely available. Due to the broad product portfolio, consumers can select a nootropic supplement to cater to a specific need.
The report reveals projections of up to 60% of global consumers planning to improve their health and wellness over the next year. This bodes well for the nootropic supplement market. It also notes that 79% of United States consumers say taking the supplement is vital to their overall health. 67% of global nutritional supplement users plan to continue using the supplement over the next year, and 49% of all supplement users say they would be willing to spend more on supplement.
| Attributes | Details |
|---|---|
| Nootropic Supplement Business Size (2023E) | US$ 2,200 million |
| Nootropic Supplement Business Projected Size (2033F) | US$ 4,180 million |
| Value CAGR (2023 to 2033) | 9.0% |
| Top 3 Countries Value Share | 30.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global nootropic supplement sales grew at a CAGR of 8.4% from 2018 to 2022. By 2033, sales of nootropic supplement are projected to progress at 9.0% CAGR. These products are easy to consume, fairly widely available, and have several health benefits, making them a popular choice among consumers globally.
The growing popularity of consumers wanting robust brain health resulted in high demand in the nootropic supplement market. Increasing expenditure on memory supplement is another key factor driving market growth. Consumers across the globe are shifting their preferences towards supplements containing natural ingredients. This is creating lucrative growth opportunities for nootropic supplement manufacturers.
Another industry-influencing trend is using convenient delivery forms to improve distribution channels. Companies are investing in advanced technologies to ensure products contain naturally sourced ingredients. The nootropic supplement business has grown steadily over the past decade. Aspects such as increasing awareness of cognitive health, a rising aging population, and a rise in mental health problems have subsidized this growth.
There has been a noteworthy increase in customer awareness and interest in nootropic supplement. Individuals are becoming more active in their cognitive health and looking for products to improve memory, emphasis, and overall brain function. Customers are screening a preference for natural and botanical ingredients over synthetic compounds. Ginkgo Biloba, Bacopa Monnieri, Ashwagandha, and Lion's Mane Mushroom have become popular due to their cognitive-enhancing properties.
Nootropic stacks, blends of diverse ingredients created to work synergistically to enhance cognitive benefits, are becoming increasingly popular. These stacks target precise cognitive functions such as improving memory, concentration, and mood stabilization. Easy access to e-commerce platforms has played a vital role in the sales development. Customers can easily research and buy products online, increasing the number of direct-to-consumer brands.
| Attributes | Key Factors |
|---|---|
| Latest Trends |
|
| Growth Hindrances |
|
| Upcoming Opportunities |
|
Principal Consultant
The United States has one of the prominently growing and leading nootropic supplement markets globally, owing to rising demand for brain health products. It is expected to reach US$ 791.8 million by 2033.
China-based businesses are still emerging players in the nootropic supplement market. However, it carries high potential as nootropic supplements in China are domestically manufactured and imported, giving consumers a wide array of choices. The market in China is expected to grow at a significant 6.8% CAGR through 2033. Research progress and widespread awareness is a key factor driving growth in the nootropic supplement market in Germany and is expected to drive growth at 3.3% CAGR in the market through 2033.
| Countries | CAGR (2023 to 2033) |
|---|---|
| United States | 7.8% |
| China | 6.8% |
| Germany | 3.3% |
The United States nootropic supplement market is poised to exhibit a CAGR of 7.8% during the assessment period. By 2033, the United States' size is expected to reach US$ 791.8 million. Nootropic supplement is categorized as dietary supplement by the FDA. They carry fewer stringent regulations than pharmaceutical drugs, as these supplements are primarily sold over the counter.
Nootropic supplement is primarily purchased online. This opens up the convenience of getting the product from various manufacturers and brands all in one place. The ease of purchase has made it simple for customers to explore their options and compare products. The consumer base in the United States includes students as it helps them with exams, professionals use it for work productivity, and older adults use it to keep sharp as they age. This has created peak interest in manufacturers' minds to develop nootropic supplements while considering all age groups.
Nootropic supplement market in China is anticipated to rise at a steady CAGR of 6.8% during the forecast period from 2023 to 2033. The Chinese government has steadily standardized the rules and regulations regarding health products and dietary supplements. These rules and regulations include product labeling requirements and sourcing regulations to improve safety and product quality.
Regarding the variety of supplements, locally manufactured and imported nootropic supplement is available in China. These varieties include herbal and natural supplements as well as synthetic additives. Manufacturers in China focus on creating unique formulations to gain a share in the global ecosystem. As studies regarding cognitive health advance, it is expected to bring forth new lucrative opportunities for key players.
The United Kingdom's nootropic supplement market is expected to reach a valuation of around US$ 175.3 million by 2033. The key factor contributing to the growth of the nootropic supplement market in the United Kingdom is its significant population, which focuses on natural and more sustainable solutions. Rising wellness and self-care trends have influenced consumers even more, boosting sales in the nootropic supplement market.
Several natural ingredients-based nootropic supplements have minimalistic side effects compared to their synthetic counterparts. This raises fewer concerns among potential consumers regarding the risk associated. Furthermore, health-related campaigns and online resources help influence consumers regarding the benefits of a natural nootropic supplement derived from plants and herbs.
Canada is one of the countries with a significant share of the elderly population globally. With this demographic shift comes increased awareness of cognitive health and greater interest in goods that support brain purpose and memory. Canada has specific guidelines regarding dietary supplement manufacture, counting nootropics. The Canadian government has recognized standards for safety, quality, and labeling.
Canada’s customers often favor natural and traditional ingredients. Products that contain herbs and botanicals that are well-known and used in conventional medicine may be especially appealing. Consumers are famous for their high standards of product superiority and safety. Businesses that want to succeed must prioritize raw material quality and experience rigorous testing.
The nootropic supplement market is expected to surge at a CAGR of 3.3% in Germany by 2033. Educational campaigns about the cognitive health and benefits of nootropic supplements can help build consumer confidence in this product category. Canada is known for its technological progress and research capabilities. Companies engaged in cutting-edge cognitive health research and developing innovative nootropic products can succeed.
Canadian consumers tend to value brands that are reputable and trustworthy. Companies with a reputation for quality and dependability may have an advantage in gaining customer trust. As e-commerce grows, several consumers still favor buying products over traditional retail channels. Creating partnerships with regional distributors or retailers can be beneficial.
Being sensitive to German culture and customs is significant for a thriving industry. This comprises considerations around packaging, messaging, and promotional activities. Constructing relationships with medical professionals and receiving their endorsements or referrals can effectively build customer credibility and trust.
| Segment | Market Value (2023) |
|---|---|
| Natural (Ingredient Type) | US$ 2,546.8 million |
| Over-the-Counter (Product category) | US$ 3,130.1 million |
| Capsules/Tablets(Form) | US$ 2,174.3 million |
Based on ingredient type, demand is expected to remain high for naturally sourced ingredients during the assessment period. With a noteworthy share of around 69.3%, the natural ingredient types segment is projected to reach a valuation of US$ 2,546.8 million in 2033.
Naturally sourced ingredients used for the formulation of nootropic supplements are preferred by consumers due to their significant neuro-enhancement and neuroprotective benefits. One of these ingredients is Gingko Biloba, which is primarily used to improve perceptual and motor functions. According to the market report, Ginseng has consistently improved in the cognitive area across sports. For instance, an individual in the education profession might go for ashwagandha as it shows better results in improving social cognition.
The over-the-counter segment is anticipated to thrive at 8.6% CAGR during the projection period to reach a valuation of US$ 3,130.1 million in 2033. The over-the-counter (OTC) supplement category products do not require a prescription. This supplement segment caters to all age groups, from minors to senior citizens, to treat minor health problems.
Furthermore, the price of any nootropic supplement sold through OTC is less expensive when compared to a prescription-based supplement. The primary factor contributing to the growth of the OTC product category is the ease of accessibility that it provides. Consumers can readily buy this supplement category at pharmacies, drug stores, and online retailers.
The capsules/tablets segment is expected to register a CAGR of 6.5% from 2023 to 2033. The target segment will likely reach US$ 2,174.3 million by the end of 2033. Factors such as the longer shelf life of capsules/tablets concerning powder or drinks form easy to store, consume, and transport contribute to the growth of the capsules/tablets format.
According to market analysis, consumers are getting pickier, with approximately 58% stating that their supplement is essential to taste good. Convenience is paramount, whether they are opting for traditional tablets and capsules or simply looking for a delivery form that's fun for them to take.
The online retailers segment is expected to register a CAGR of 8.6% from 2018 to 2022 and a CAGR of 9.1% from 2023 to 2033. The convenience and accessibility offered by online platforms have revolutionized how consumers shop, enabling them to browse and purchase products from the comfort of their homes. Nootropic supplement, known for its health benefits regarding brain health support, can now reach a wider audience through these digital channels.
By utilizing e-commerce and online retail platforms, nootropics supplement manufacturers and suppliers can access a global business, surpassing geographical limitations and reaching customers beyond traditional retail boundaries. This expansion creates opportunities for increased sales and revenue generation. Online channels offer comprehensive product information, customer reviews, and recommendations, which contribute to building consumer trust and confidence in nootropic supplements.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The ecosystem offers a wide range of products that provide individual and nootropics stacks (combinations of different nootropics) targeting brain health. Several companies have been engaged in the nootropics supplement trade. Several established players and several medium and small-sized players categorize the industry. Product launches are key growth initiatives businesses undertake to gain a competitive advantage. Product manufacturers are presenting new variations in the nootropic product category to appeal to a broader customer base.
For instance,
| Attribute | Details |
|---|---|
| Estimated Nootropic Supplement Size (2023) | US$ 2,200 million |
| Projected Nootropic Supplement Valuation (2033) | US$ 4,180 million |
| Value-based CAGR (2023 to 2033) | 9.0% |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Sales Analysis | US$ million for Value, Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; and the Middle East and Africa |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, United Kingdom, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, and others. |
| Key Segments Covered | Ingredient Type, Product Category, Form, Sales Channel |
| Key Companies Profiled | Onnit Labs; Mental Mojo LLC; NooCube; Mind Lab Pro; TruBrain; Peak Nootropics; Zhou Nutrition; Kimera Koffee; Neu Drink; Accelerated Intelligence Inc; AlternaScript LLC; Cephalon Inc.; SupNootropic Bio Co. Ltd.; Teva Pharmaceutical Industries Ltd; Nootrobox Inc. |
Throughout the forecast period, the nootropic supplement business is expected to grow at a CAGR of 9.0%.
By 2033, the nootropic supplement ecosystem is expected to be worth US$ 4,180 million.
The natural ingredient type segment will likely garner a value share of 64.3% by 2023
The online retailers segment under sales channel category is predicted to grow significantly.
Some of the key players include Onnit Labs, Mental Mojo LLC, NooCube, Mind Lab Pro, TruBrain, etc.
1. Executive Summary 1.1. Global Sales Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Wheel of Fortune 1.5. Analysis and Recommendations 2. Overview 2.1. Coverage / Taxonomy 2.2. Definition of Market By Country 3. Dynamics 3.1. Drivers 3.1.1. Supply Side Drivers 3.1.2. Demand Side drivers 3.1.3. Economic Side Drivers 3.2. Restraints 3.3. Opportunity 3.4. Trends By Region 3.5. Product Launches 3.6. Product Claims & Nutritional Information Scan by Buyers 3.7. Macro-Economic Factors 3.8. Forecast Factors - Relevance & Impact 4. Regulations 4.1. Packaging & Labelling Regulations 4.2. Certifications and Certifying Agency Overview 4.3. Import/Export Policies 4.4. Formula Requirements 4.5. Standards as per institutions 4.5.1. FDA 4.5.2. USDA 4.5.3. FASSAI 4.5.4. EU Commissions 5. Global Market- Pricing Analysis 5.1. Price Point Assessment by Region 5.1.1. Manufacturer Level Pricing 5.1.2. Distributor Level Pricing 5.1.3. Retailer Level Pricing 5.2. Price Point Assessment By Form 5.3. Factors Influencing Price 6. Value Chain Analysis 6.1. Operating margins at each node of supply chain 6.2. List of Active Participants 6.2.1. Raw Material Suppliers 6.2.2. Product Manufacturers 7. Global Market Size (in Value (US$ million) and Volume (Units) Analysis 2018 to 2022 and Forecast, 2023 to 2033 7.1. Historical Size in Value (US$ million) and Volume (Units) Analysis, 2018 to 2022 7.2. Current and Future Size in Value (US$ million) and Volume (Units) Analysis, 2023 to 2033 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Ingredient Type 8.1. Introduction / Key Findings 8.2. Historical Size in Value (US$ million) and Volume (Units) Analysis By Ingredient Type, 2018 to 2022 8.3. Current and Future Size in Value (US$ million) and Volume (Units) Analysis and Forecast By Ingredient Type, 2023 to 2033 8.3.1. Natural 8.3.1.1. Panax Ginseng 8.3.1.2. Ginkgo Biloba 8.3.1.3. Asiatic Pennywort 8.3.1.4. Ashwagandha 8.3.1.5. Bacopa Monnieri 8.3.1.6. Guarana 8.3.1.7. Eleuthero 8.3.1.8. Rhodiola Rosea 8.3.1.9. Schisandra Chinensis 8.3.1.10. Others (Maca, etc.) 8.3.2. Synthetic 8.3.2.1. Racetams 8.3.2.2. Modafinil 8.3.2.3. Sunifiram 8.3.2.4. Phosphatidylserine 8.3.2.5. Choline 8.3.2.6. DMAE 8.3.2.7. Unifiram 8.3.2.8. Hydrafinil 8.3.2.9. Citicoline 8.3.2.10. Others (Adranfinil, etc.) 8.4. Business Attractiveness Analysis By Ingredient Type 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Category 9.1. Introduction / Key Findings 9.2. Historical Size (in Value (US$ million) and Volume (Units) Analysis By Product Category, 2018 to 2022 9.3. Current and Future Size (in Value (US$ million) and Volume (Units) Analysis and Forecast By Product Category, 2023 to 2033 9.3.1. Prescribed 9.3.2. Over-the-Counter 9.4. Business Attractiveness Analysis By Product Category 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Form 10.1. Introduction / Key Findings 10.2. Historical Size (in Value (US$ million) and Volume (Units) Analysis By Form, 2018 to 2022 10.3. Current and Future Size (in Value (US$ million) and Volume (Units) Analysis and Forecast By Form, 2023 to 2033 10.3.1. Capsules/Tablets 10.3.2. Powder 10.3.3. Drinks 10.3.4. Gummy 10.4. Business Attractiveness Analysis By Form 11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel 11.1. Introduction / Key Findings 11.2. Historical Size in Value (US$ million) and Volume (Units) Analysis By Distribution Channel, 2018 to 2022 11.3. Current and Future Size in Value (US$ million) and Volume (Units) Analysis and Forecast By Distribution Channel, 2023 to 2033 11.3.1. Health Food Stores 11.3.2. Pharmacies and Drugstores 11.3.3. Professional Healthcare Practitioners 11.3.4. Nutrition Stores 11.3.5. Healthcare Professionals 11.3.6. Online Retailers 11.4. Business Attractiveness Analysis By Distribution Channel 12. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region 12.1. Introduction 12.2. Historical Size in Value (US$ million) and Volume (Units) Analysis By Region, 2018 to 2022 12.3. Current Size in Value (US$ million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East & Africa 12.4. Business Attractiveness Analysis By Region 13. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13.1. Historical Size (US$ million) and Volume Trend Analysis By Taxonomy, 2018 to 2022 13.2. Forecast Size (US$ million) and Volume Forecast By Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. United States 13.2.1.2. Canada 13.2.2. By Ingredient Type 13.2.3. By Product Category 13.2.4. By Form 13.2.5. By Distribution Channel 13.3. Business Attractiveness Analysis 13.3.1. By Country 13.3.2. By Ingredient Type 13.3.3. By Product Category 13.3.4. By Form 13.3.5. By Distribution Channel 13.4. Trends 13.5. Key Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14.1. Historical Size (US$ million) and Volume Trend Analysis By Taxonomy, 2018 to 2022 14.2. Forecast Size (US$ million) and Volume Forecast By Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Brazil 14.2.1.2. Mexico 14.2.1.3. Colombia 14.2.1.4. Argentina 14.2.1.5. Rest of Latin America 14.2.2. By Ingredient Type 14.2.3. By Product Category 14.2.4. By Form 14.2.5. By Distribution Channel 14.3. Business Attractiveness Analysis 14.3.1. By Country 14.3.2. By Ingredient Type 14.3.3. By Product Category 14.3.4. By Form 14.3.5. By Distribution Channel 14.4. Trends 14.5. Key Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15.1. Historical Size (US$ million) and Volume Trend Analysis By Taxonomy, 15.2. Forecast Size (US$ million) and Volume Forecast By Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. Germany 15.2.1.2. United Kingdom 15.2.1.3. France 15.2.1.4. Italy 15.2.1.5. Spain 15.2.1.6. BENELUX 15.2.1.7. Nordic 15.2.1.8. Russia 15.2.1.9. Poland 15.2.1.10. Rest of Europe 15.2.2. By Ingredient Type 15.2.3. By Product Category 15.2.4. By Form 15.2.5. By Distribution Channel 15.3. Business Attractiveness Analysis 15.3.1. By Country 15.3.2. By Ingredient Type 15.3.3. By Product Category 15.3.4. By Form 15.3.5. By Distribution Channel 15.4. Trends 15.5. Key Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16.1. Historical Size (US$ million) and Volume Trend Analysis By Taxonomy, 2018 to 2022 16.2. Forecast Size (US$ million) and Volume Forecast By Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. China 16.2.1.2. Japan 16.2.1.3. South Korea 16.2.2. By Ingredient Type 16.2.3. By Product Category 16.2.4. By Form 16.2.5. By Distribution Channel 16.3. Business Attractiveness Analysis 16.3.1. By Country 16.3.2. By Ingredient Type 16.3.3. By Product Category 16.3.4. By Form 16.3.5. By Distribution Channel 16.4. Trends 16.5. Key Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 17.1. Historical Size (US$ million) and Volume Trend Analysis By Taxonomy, 2018 to 2022 17.2. Forecast Size (US$ million) and Volume Forecast By Taxonomy, 2023 to 2033 17.2.1. By Country 17.2.1.1. India 17.2.1.2. Thailand 17.2.1.3. Malaysia 17.2.1.4. Indonesia 17.2.1.5. Singapore 17.2.1.6. Rest of South Asia 17.2.2. By Ingredient Type 17.2.3. By Product Category 17.2.4. By Form 17.2.5. By Distribution Channel 17.3. Business Attractiveness Analysis 17.3.1. By Country 17.3.2. By Ingredient Type 17.3.3. By Product Category 17.3.4. By Form 17.3.5. By Distribution Channel 17.4. Trends 17.5. Key Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033 18.1. Historical Size (US$ million) and Volume Trend Analysis By Taxonomy, 2018 to 2022 18.2. Forecast Size (US$ million) and Volume Forecast By Taxonomy, 2023 to 2033 18.2.1. By Country 18.2.1.1. Australia 18.2.1.2. New Zealand 18.2.2. By Ingredient Type 18.2.3. By Product Category 18.2.4. By Form 18.2.5. By Distribution Channel 18.3. Business Attractiveness Analysis 18.3.1. By Country 18.3.2. By Ingredient Type 18.3.3. By Product Category 18.3.4. By Form 18.3.5. By Distribution Channel 18.4. Trends 18.5. Key Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 19.1. Historical Size (US$ million) and Volume Trend Analysis By Taxonomy, 2018 to 2022 19.2. Forecast Size (US$ million) and Volume Forecast By Taxonomy, 2023 to 2033 19.2.1. By Country 19.2.1.1. UAE 19.2.1.2. Saudi Arabia 19.2.1.3. Other GCC Countries 19.2.1.4. North Africa 19.2.1.5. South Africa 19.2.1.6. Central Africa 19.2.2. By Ingredient Type 19.2.3. By Product Category 19.2.4. By Form 19.2.5. By Distribution Channel 19.3. Business Attractiveness Analysis 19.3.1. By Country 19.3.2. By Ingredient Type 19.3.3. By Product Category 19.3.4. By Form 19.3.5. By Distribution Channel 19.4. Trends 19.5. Key Participants - Intensity Mapping 19.6. Drivers and Restraints - Impact Analysis 20. Country-level Market Analysis, 2023 20.1. United States Market Analysis 20.1.1. By Ingredient Type 20.1.2. By Product Category 20.1.3. By Form 20.1.4. By Distribution Channel 20.2. Canada Market Analysis 20.2.1. By Ingredient Type 20.2.2. By Product Category 20.2.3. By Form 20.2.4. By Distribution Channel 20.3. Brazil Market Analysis 20.3.1. By Ingredient Type 20.3.2. By Product Category 20.3.3. By Form 20.3.4. By Distribution Channel 20.4. Mexico Market Analysis 20.4.1. By Ingredient Type 20.4.2. By Product Category 20.4.3. By Form 20.4.4. By Distribution Channel 20.5. Colombia Market Analysis 20.5.1. By Ingredient Type 20.5.2. By Product Category 20.5.3. By Form 20.5.4. By Distribution Channel 20.6. Argentina Market Analysis 20.6.1. By Ingredient Type 20.6.2. By Product Category 20.6.3. By Form 20.6.4. By Distribution Channel 20.7. Germany Market Analysis 20.7.1. By Ingredient Type 20.7.2. By Product Category 20.7.3. By Form 20.7.4. By Distribution Channel 20.8. United States Market Analysis 20.8.1. By Ingredient Type 20.8.2. By Product Category 20.8.3. By Form 20.8.4. By Distribution Channel 20.9. France Market Analysis 20.9.1. By Ingredient Type 20.9.2. By Product Category 20.9.3. By Form 20.9.4. By Distribution Channel 20.10. Italy Market Analysis 20.10.1. By Ingredient Type 20.10.2. By Product Category 20.10.3. By Form 20.10.4. By Price Range 20.10.5. By Distribution Channel 20.11. Spain Market Analysis 20.11.1. By Ingredient Type 20.11.2. By Product Category 20.11.3. By Form 20.11.4. By Distribution Channel 20.12. Belgium Market Analysis 20.12.1. By Ingredient Type 20.12.2. By Product Category 20.12.3. By Form 20.12.4. By Distribution Channel 20.13. Netherlands Market Analysis 20.13.1. By Ingredient Type 20.13.2. By Product Category 20.13.3. By Form 20.13.4. By Distribution Channel 20.14. Nordic Market Analysis 20.14.1. By Ingredient Type 20.14.2. By Product Category 20.14.3. By Form 20.14.4. By Distribution Channel 20.15. Russia Market Analysis 20.15.1. By Ingredient Type 20.15.2. By Product Category 20.15.3. By Form 20.15.4. By Distribution Channel 20.16. Poland Market Analysis 20.16.1. By Ingredient Type 20.16.2. By Product Category 20.16.3. By Form 20.16.4. By Distribution Channel 20.17. Ukraine Market Analysis 20.17.1. By Ingredient Type 20.17.2. By Product Category 20.17.3. By Form 20.17.4. By Distribution Channel 20.18. China Market Analysis 20.18.1. By Ingredient Type 20.18.2. By Product Category 20.18.3. By Form 20.18.4. By Distribution Channel 20.19. Japan Market Analysis 20.19.1. By Ingredient Type 20.19.2. By Product Category 20.19.3. By Form 20.19.4. By Distribution Channel 20.20. S Korea Market Analysis 20.20.1. By Ingredient Type 20.20.2. By Product Category 20.20.3. By Form 20.20.4. By Distribution Channel 20.21. India Market Analysis 20.21.1. By Ingredient Type 20.21.2. By Product Category 20.21.3. By Form 20.21.4. By Distribution Channel 20.22. Thailand Market Analysis 20.22.1. By Ingredient Type 20.22.2. By Product Category 20.22.3. By Form 20.22.4. By Distribution Channel 20.23. Malaysia Market Analysis 20.23.1. By Ingredient Type 20.23.2. By Product Category 20.23.3. By Form 20.23.4. By Distribution Channel 20.24. Indonesia Market Analysis 20.24.1. By Ingredient Type 20.24.2. By Product Category 20.24.3. By Form 20.24.4. By Distribution Channel 20.25. Singapore Market Analysis 20.25.1. By Ingredient Type 20.25.2. By Product Category 20.25.3. By Form 20.25.4. By Distribution Channel 20.26. Australia Market Analysis 20.26.1. By Ingredient Type 20.26.2. By Product Category 20.26.3. By Form 20.26.4. By Distribution Channel 20.27. New Zealand Market Analysis 20.27.1. By Ingredient Type 20.27.2. By Product Category 20.27.3. By Form 20.27.4. By Distribution Channel 20.28. UAE Market Analysis 20.28.1. By Ingredient Type 20.28.2. By Product Category 20.28.3. By Form 20.28.4. By Distribution Channel 20.29. Saudi Arabia Market Analysis 20.29.1. By Ingredient Type 20.29.2. By Product Category 20.29.3. By Form 20.29.4. By Distribution Channel 20.30. North Africa Market Analysis 20.30.1. By Ingredient Type 20.30.2. By Product Category 20.30.3. By Form 20.30.4. By Distribution Channel 20.31. South Africa Market Analysis 20.31.1. By Ingredient Type 20.31.2. By Product Category 20.31.3. By Form 20.31.4. By Distribution Channel 20.32. Central Africa Market Analysis 20.32.1. By Ingredient Type 20.32.2. By Product Category 20.32.3. By Form 20.32.4. By Distribution Channel 21. Structure Analysis 21.1. Global Market Competition - a Dashboard View 21.2. Industry Structure Analysis 21.2.1. % tier 1 players 21.2.2. % tier 2 players 21.2.3. % tier 3 players 21.3. Global Market Company Share Analysis 21.3.1. For Tier 1 Players, 2022 21.3.2. Company Share Analysis of Top 5 Players, By Region 22. Competition Analysis 22.1. Competition Deep Dive 22.1.1. Onnit Labs 22.1.1.1. Product Portfolio 22.1.1.2. Product Claim 22.1.1.3. Revenue by Segments (Product/Channel/Region) 22.1.1.4. Sales Footprint 22.1.1.5. Strategy Overview 22.1.1.5.1. Marketing Strategy 22.1.1.5.2. Product Strategy 22.1.1.5.3. Channel Strategy 22.1.1.6. SWOT Analysis 22.1.2. Mental Mojo LLC 22.1.2.1. Product Portfolio 22.1.2.2. Product Claim 22.1.2.3. Revenue by Segments (Product/Channel/Region) 22.1.2.4. Sales Footprint 22.1.2.5. Strategy Overview 22.1.2.5.1. Marketing Strategy 22.1.2.5.2. Product Strategy 22.1.2.5.3. Channel Strategy 22.1.2.6. SWOT Analysis 22.1.3. NooCube 22.1.3.1. Product Portfolio 22.1.3.2. Product Claim 22.1.3.3. Revenue by Segments (Product/Channel/Region) 22.1.3.4. Sales Footprint 22.1.3.5. Strategy Overview 22.1.3.5.1. Marketing Strategy 22.1.3.5.2. Product Strategy 22.1.3.5.3. Channel Strategy 22.1.3.6. SWOT Analysis 22.1.4. Mind Lab Pro 22.1.4.1. Product Portfolio 22.1.4.2. Product Claim 22.1.4.3. Revenue by Segments (Product/Channel/Region) 22.1.4.4. Sales Footprint 22.1.4.5. Strategy Overview 22.1.4.5.1. Marketing Strategy 22.1.4.5.2. Product Strategy 22.1.4.5.3. Channel Strategy 22.1.4.6. SWOT Analysis 22.1.5. TruBrain 22.1.5.1. Product Portfolio 22.1.5.2. Product Claim 22.1.5.3. Revenue by Segments (Product/Channel/Region) 22.1.5.4. Sales Footprint 22.1.5.5. Strategy Overview 22.1.5.5.1. Marketing Strategy 22.1.5.5.2. Product Strategy 22.1.5.5.3. Channel Strategy 22.1.5.6. SWOT Analysis 22.1.6. Peak Nootropics 22.1.6.1. Product Portfolio 22.1.6.2. Product Claim 22.1.6.3. Revenue by Segments (Product/Channel/Region) 22.1.6.4. Sales Footprint 22.1.6.5. Strategy Overview 22.1.6.5.1. Marketing Strategy 22.1.6.5.2. Product Strategy 22.1.6.5.3. Channel Strategy 22.1.6.6. SWOT Analysis 22.1.7. Zhou Nutrition 22.1.7.1. Product Portfolio 22.1.7.2. Product Claim 22.1.7.3. Revenue by Segments (Product/Channel/Region) 22.1.7.4. Sales Footprint 22.1.7.5. Strategy Overview 22.1.7.5.1. Marketing Strategy 22.1.7.5.2. Product Strategy 22.1.7.5.3. Channel Strategy 22.1.7.6. SWOT Analysis 22.1.8. Kimera Koffee 22.1.8.1. Product Portfolio 22.1.8.2. Product Claim 22.1.8.3. Revenue by Segments (Product/Channel/Region) 22.1.8.4. Sales Footprint 22.1.8.5. Strategy Overview 22.1.8.5.1. Marketing Strategy 22.1.8.5.2. Product Strategy 22.1.8.5.3. Channel Strategy 22.1.8.6. SWOT Analysis 22.1.9. Neu Drink 22.1.9.1. Product Portfolio 22.1.9.2. Product Claim 22.1.9.3. Revenue by Segments (Product/Channel/Region) 22.1.9.4. Sales Footprint 22.1.9.5. Strategy Overview 22.1.9.5.1. Marketing Strategy 22.1.9.5.2. Product Strategy 22.1.9.5.3. Channel Strategy 22.1.9.6. SWOT Analysis 22.1.10. Accelerated Intelligence Inc. 22.1.10.1. Product Portfolio 22.1.10.2. Product Claim 22.1.10.3. Revenue by Segments (Product/Channel/Region) 22.1.10.4. Sales Footprint 22.1.10.5. Strategy Overview 22.1.10.5.1. Marketing Strategy 22.1.10.5.2. Product Strategy 22.1.10.5.3. Channel Strategy 22.1.10.6. SWOT Analysis 22.1.11. AlternaScript LLC 22.1.11.1. Product Portfolio 22.1.11.2. Product Claim 22.1.11.3. Revenue by Segments (Product/Channel/Region) 22.1.11.4. Sales Footprint 22.1.11.5. Strategy Overview 22.1.11.5.1. Marketing Strategy 22.1.11.5.2. Product Strategy 22.1.11.5.3. Channel Strategy 22.1.11.6. SWOT Analysis 22.1.12. Cephalon Inc. 22.1.12.1. Product Portfolio 22.1.12.2. Product Claim 22.1.12.3. Revenue by Segments (Product/Channel/Region) 22.1.12.4. Sales Footprint 22.1.12.5. Strategy Overview 22.1.12.5.1. Marketing Strategy 22.1.12.5.2. Product Strategy 22.1.12.5.3. Channel Strategy 22.1.12.6. SWOT Analysis 22.1.13. SupNootropic bio co. ltd. 22.1.13.1. Product Portfolio 22.1.13.2. Product Claim 22.1.13.3. Revenue by Segments (Product/Channel/Region) 22.1.13.4. Sales Footprint 22.1.13.5. Strategy Overview 22.1.13.5.1. Marketing Strategy 22.1.13.5.2. Product Strategy 22.1.13.5.3. Channel Strategy 22.1.13.6. SWOT Analysis 22.1.14. Teva Pharmaceutical Industries Ltd 22.1.14.1. Product Portfolio 22.1.14.2. Product Claim 22.1.14.3. Revenue by Segments (Product/Channel/Region) 22.1.14.4. Sales Footprint 22.1.14.5. Strategy Overview 22.1.14.5.1. Marketing Strategy 22.1.14.5.2. Product Strategy 22.1.14.5.3. Channel Strategy 22.1.14.6. SWOT Analysis 22.1.15. Nootrobox Inc. 22.1.15.1. Product Portfolio 22.1.15.2. Product Claim 22.1.15.3. Revenue by Segments (Product/Channel/Region) 22.1.15.4. Sales Footprint 22.1.15.5. Strategy Overview 22.1.15.5.1. Marketing Strategy 22.1.15.5.2. Product Strategy 22.1.15.5.3. Channel Strategy 22.1.15.6. SWOT Analysis 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Food and Beverage Insights
View Reports
Nootropic Supplement Market
